Difference between revisions of "Category:Tryptophan hydroxylase inhibitors"
Jump to navigation
Jump to search
m |
m |
||
| Line 2: | Line 2: | ||
[[Category:Endocrine therapy]] | [[Category:Endocrine therapy]] | ||
| + | [[Category:Enzyme inhibitors]] | ||
Revision as of 17:30, 21 July 2017
Tryptophan hydroxylase controls the rate limiting step of the biosynthesis of serotonin, which plays a role in regulating the secretion, motility, inflammation, and sensation of the gastrointestinal tract, and is over-produced in patients with carcinoid syndrome.
Pages in category "Tryptophan hydroxylase inhibitors"
This category contains only the following page.